The mainstreaming of healthy beverages and CBD-infused consumer products has reached a new level with a development that’s shaking up multiple industries throughout North America and abroad.
We introduced this stock to you on September 4th, 2018, and I am personally about to increase my own position in the company. They continue to take very serious steps in the beverage market, and it is becoming a core holding of mine.
We first covered it at just 15 cents, and then saw it run to 74 cents, however, its recent pull back has created a very discounted entry point relative to what the company has achieved in the last 6 months.
Despite improving their business and comparatively sitting at about where Bai was at this stage of their business, because of their exposure to the CBD market, the stock itself actually fell with the cannabis market pullback that started in November. However, this was a huge mistake because it’s not a cannabis company, it’s a health beverage business, that happens to also own a cannabis infused beverage company in addition to all of their other activities
Today, we can pick shares up for 23 cents, which is honestly an absurdly low market valuation for a company like this. That’s why I love it!
In my opinion, Koios Beverage Corp. has created one of the world’s safest, most natural, and science-driven beverage and supplement products to help you and your brain achieve optimal performance.
Founded in January 2014 by Chris Miller, Koios Beverage Corp. (CAD: KBEV; USD: KBEVF) is quickly becoming the global leader in proprietary, patented, and clinically proven formulas for their flagship brand, KOIOS beverages and supplements.
Chris created Koios out of the huge need he saw in the marketplace for sustainable and Earth-grown products that could enhance human productivity. Within the first three years of operation, Koios was reaching hundreds of thousands of people around the United States and Canada through high-level marketing and sales efforts, as well as the best products in the niche.
But that was really only the beginning, as Koios’ early efforts were directed towards beverages and supplements infused with nootropics, which are supplements or other substances that improve cognitive function, particularly executive functions, memory, creativity, and/or motivation in healthy individuals.
Koios’ products are still infused with brain-enhancing nootropics, as this remains a massive market that’s expected to exceed $6 billion by 2024, expanding at a CAGR of 17.9% from 2016 to 2024:
The runaway success of Koios’ healthy products is the direct result of founder Chris Miller’s personal struggle to find a better performance-enhancing alternative to caffeine and prescription drugs: “I believed there had to be a better way. Better technology that the earth was providing that I could implement and not only boost my daily performance but take care of my brain and body long-term.”
His line of functional and delicious nootropic-enhanced beverages and supplements turned out to be the perfect solution to this problem. Many consumers evidently agree with this assessment, as Koios soon became the leader in the North American nootropic market.
We’re now seeing Koios products practically everywhere: GNC, 7-11, Gold’s Gym, Amazon, Conoco, Wishing-U-Well… The list goes on and on. But that’s just the beginning of the journey, as Chris Miller had another goal in mind: to launch a line of CBD-infused beverages as part of Koios’ already impressive offering of nootropic-enhanced drinks.
So that’s exactly what he did: Chris and Koios rolled out a line of beverages containing non-THC hemp oil. Hemp oil contains the perfect balance of Omega-3s and Omega-6s for optimal health benefits, and with the recent passage of the Farm Bill, which federally legalized hemp in the U.S., Chris’ timing for his CBD-added beverages couldn’t have been better.
Koios Beverage Corp. has signed a retail deal with internationally recognized health and wellness retail chain GNC Holdings Inc.
This big-time vendor agreement with GNC means that Koios will have potential access to over 6,400 high-traffic retail locations throughout the United States and Canada. Throughout 2019, Chris Miller and Koios will remain focused on the company’s retail rollout and fulfilling the GNC deal.
Koios’ headline-grabbing partnership with GNC means that the company’s products will be in thousands of new locations very soon. In fact, Chris Miller recently projected that he’s anticipating over 5,000 locations in 2019 and close to 10,000 in 2020.
Could all of this exposure make Koios a potential target for a large-scale capital infusion from a beverage mega-corporation, like what we’ve seen with Constellation Brands, Anheuser-Busch InBev, and Molson Coors?
Consider accumulating shares of Koios Beverage Corp (US: KBEVF & CAD: KBEV).
Legal Notice: This work is based on SEC filings, current events, interviews, corporate press releases and what we’ve learned as financial journalists. It may contain errors and you shouldn’t make any investment decision based solely on what you read here. It’s your money and your responsibility. The information herein is not intended to be personal legal or investment advice and may not be appropriate or applicable for all readers. If personal advice is needed, the services of a qualified legal, investment or tax professional should be sought.
Never base any decision off of our emails. FutureMoneyTrends.com stock profiles are intended to be stock ideas, NOT recommendations. The ideas we present are high risk and you can lose your entire investment, we are not stock pickers, market timers, investment advisers, and you should not base any investment decision off our website, emails, videos, or anything we publish. Please do your own research before investing. It is crucial that you at least look at current SEC filings and read the latest press releases. Information contained in this profile was extracted from current documents filed with the SEC, the company web site and other publicly available sources deemed reliable. Never base any investment decision from information contained in our website or emails or any or our publications. Our report is not intended to be, nor should it be construed as an offer to buy or sell, or a solicitation of an offer to buy or sell securities, or as a recommendation to purchase anything. This publication may provide the addresses or contain hyperlinks to websites; we disclaim any responsibility for the content of any such other websites. We have entered into an agreement for three hundred thousand dollars and five hundred thousand options paid for directly by the company. We have also purchased shares and are long the company. Please use our site as a place to get ideas. Enjoy our videos and news analysis, but never make an investment decision off of anything we say. Please review our entire disclaimer at FutureMoneyTrends.com.